診療科・部門紹介
診療科・部門紹介

食道外科

食道外科

最終更新日 : 2023年5月16日

診療科の特徴｜診療実績｜スタッフ紹介｜論文実績

論文実績

【2022】

  1. Kanie Y, Okamura A, Kanamori J, Imamura Y, Kamiyama R, Seto A, Shimbashi W, Sasaki T, Fukushima H, Mitani H, Watanabe M. Postoperative complications following pharyngolaryngectomy with total esophagectomy: Comparison between cervical and anterior mediastinal trachestomy. Ann Otol Rhino Laryngol. 2022; 11: 34894221118421.
  2. Matsuda S, Kitagawa Y, Takemura R, Okui J, Okamura A, Kawakubo H, Muto M, Kakeji Y, Takeuchi H, Watanabe M, Doki Y. Real-world evaluation of the efficacy of neoadjuvant DCF over CF in esophageal squamous cell carcinoma: Propensity score matched analysis from 85 authorized institutes for esophageal cancer in Japan. Ann Surg. Online ahead of print.
  3. Maruyama S, Okamura A, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Takeda K, Watanabe M. Fecal microbes associated with the outcomes after esophagectomy in patients with esophageal cancer. AnnSurg Oncol 2022; 29: 7448-7457.
  4. Okamura A, Yoshimizu S, Kanamori J, Imamura Y, Asari T, Nakayama I, Ogura M, Ishiyama A, Yoshio T, Chin K, Fujisaki J, Watanabe M. Treatment strategy for esophageal squamous cell carcinoma with endoscopic intramural metastasis. Creus 2022; 14: e23028.
  5. Fujiwara D, Watanabe M, Kanie Y, Maruyama S, Sakamoto K, Okamura A, Kanamori J, Imamura Y, Mine S. Is prophylactic cervical drainage effective in patients undergoing McKeown esophagectomy reconstructed through the retrosternal route with two-field lymphadenectomy? World J Surg 2022; 46: 1944-1951.
  6. Maruyama S, Okamura A, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Kumagai K, Watanabe M. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbecks Arch Surg 2022; 407: 1901-1909.
  7. Ishikawa S, Ozato S, Ebina T, Yoshioka S, Miichi M, Watanabe M, Yokota M. Early postoperative pulmonary complications after minimally invasive esophagectomy in the prone position: incidence and perioperative risk factors from the perspective of anesthetic management. Gen Thorac Cardiovasc Surg. 2022; 70: 659-667.
  8. Watanabe M, Toh Y, Ishihara R, Kono K, Matsubara H, Murakami K, Muro K, Numasaki H, Oyama T, Ozawa S, Saeki H, Tanaka K, Tsushima T, Ueno M, Uno T, Yoshio T, Usune S, Takahashi A, Miyata H. Comprehensive registry of esophageal cancer in Japan, 2014. Esophagus 2022; 19: 1-26.
  9. Suzuki T, Okamura A, Watanabe M, Asari T, Nakayama I, Ogura M, Ooki A, Takahari D, Yamaguchi K, Chin K. Serum squamous cell carcinoma antigen is a predictive factor of outcomes in patients with locally advanced unresectable esophageal squamous cell carcinoma treated by definitive chemoradiotherapy. J Cancer Metastasis Treat 2022; 8: 5.
  10. Kanie Y, Okamura A, Fujihara A, Matsuo H, Maruyama S, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Kumagai K, Watanabe M. Long-term insufficiency of oral inktake after esophagectomy: Who needs intense nutritional support after esophagectomy. Ann Nutr Metab, 2022; 78: 106-113.
  11. Naito S, Yoshio T, Ishiyama A, Tsuchida T, Tokura J, Namikawa K, Tokai Y, Yoshimizu S, Horiuchi Y, Hirakawa T, Asari T, Mine S, Watanabe M, Ogura M, Chin K, Fukuzawa M, Itoi T, Fujisaki J. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endocscopic resection followed by appropriate additional treatment. Dig Endosc 2022; 34: 793-804.
  12. Kurogochi T, Honda M, Takahashi K, Okamura A, Imamura Y, Yamashita K, Kamiya S, hayami M, Mine S, Watanabe M. Clinical features and risk factors of early recurrence after esophagectomy following neoadjuvant chemotherapy for esophageal cancer. Surg Today 2022; 52: 660-667.
  13. Okamura A, Yamamoto H, Watanabe M, Miyata H, Kanaji S, Kamiya K, Kakeji Y, Doki Y, Kitagawa Y. Association between preoperative HbA1c levels and complications after esophagectomy: Analysis of 15,801 esophagectomies from the National Clinical Database in Japan. Ann Surg, 2022; 276: e393-399.
  14. Matsuda S, Kawakubo H, Okamura A, Takahashi K, Toihata T, Takemura R, Mayanagi S, Hirata K, Irino T, Hamamoto Y, Takeuchi H, Watanabe M, Kitagawa Y. Distribution of residual disease and recurrence patterns in pathological responders after neoadjuvant chemotharapy for esophageal squamous cell carcinoma. Ann Surg 2022; 276: 298-304.
  15. Kozuki R, Watanabe M, Toihata T, Takahashi K Otake R, Okamura A, Imamura Y, Mine S. Treatment strategies and outcomes for elderly patients with locally advanced squamous cell carcinoma of the esophagus. Surg Today 2022; 52: 377-384.
  16. Kanamori J, Watanabe M, Maruyama S, Kanie Y, Fujiwara D, Sakamoto K, Okamura A, Imamura Y. Cirrent status of robot-assisted minimally invasive esophagectomy: what is the real benefit? Surg Today 2022; 52: 1246-1253.
  17. Maruyama S, Okamura A, Takeda K, Watanabe M. ASO author reflections: Are fecal microbes associated with outcomes after esophageal cancer surgery? Ann Surg Oncol 2022; 29: 7458-7459.
  18. Maruyama S, Okamura A, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Takeda K, Watanabe M. ASO visual abstract: Fecal microbes associated with the outcomes after esophagectomy in patients with esophageal cancer. Ann Surg Oncol 2022; 29: 7460-7461.
  19. Watanabe M, Okamura A, Kanamori J, Imamura Y, Kuriyama K, Sakamoto K, Kanie Y, Maruyama S. Three-dimentional model to simulate esophagectomy in patients with a mediastinal vascular anatomy: to see is to believe. Transl Cancer Res 2022; 11: 3443-3444.
  20. Zhang CD, Takeshima H, Sekine S, Yamashita S, Liu YY, Hattori N, Abe H, Yamashita H, Fukuda M, Imamura Y, Ushiku T, Katai H, Makino H, Watanabe M, Seto Y, Ushijima T. Prediction of tissue origin of adenocarcinomas in esophagogastric junction by DNA methylation. Gastric Cancer, 2022; 25: 336-345.
  21. Oshikiri T, Numasaki H, Oguma J, Toh Y, Watanabe M, Muto M, Doki Y, Kakeji Y. Prognosis of patients with esophageal carcinoma following routine thoracic duct resection: A propensity matched-analysis of 12,237 patients based on the Comprehensive Registry of Esophageal Cancer in Japan. Ann Surg, online ahead of print.
  22. 丸山傑、岡村明彦、蟹江恭和、坂本啓、藤原大介、渡邊雅之：特集　上部消化管領域再建手技-最近のトピック　三辺外翻三角吻合による食道胃管吻合．手術 2022; 76: 155-160.
  23. 金森淳、渡邊雅之、丸山傑、藤原大介、蟹江恭和、藤原大介、坂本啓、岡村明彦、今村裕：切除不能食道扁平上皮癌に対する食道バイパス術20例の治療成績．日本気管食道科学会会報 2022; 73: 203-209.
  24. 今村裕、原口郁美、渡邊雅之：低レベルマイクロサテライト不安定性の発癌機構の解明と免疫治療バイオマーカーの創出．臨床薬理の進歩 2022; 43: 41-57.
  25. 渡邊雅之、藤也寸志、土岐祐一郎：食道疾患の治療　III食道癌の診察　4．食道癌治療成績の全国集計．臨床消化器内科 2022; 37: 1065-1068.
  26. 渡邊雅之、栗山健吾、蟹江恭和、丸山傑、坂本啓：チームで支える頭頚部癌診療　チームで行う頭頸部癌の手術治療　頭頸部癌の再建手術－消化器外科の立場から．JOHNS　2022; 38: 1535-1537.

【2021】

  1. Imamura Y, Toihata T, Haraguchi I, Ogata Y, Takamatsu M, Kuchiba A, Tanaka N, Gotoh O, Mori S, Nakashima Y, Oki E, Mori M, Oda Y, Taguchi K, Yamamoto M, Morita M, Yoshida N, Baba H, Mine S, Nunobe S, Sano T, Noda T, Watanabe M. Immunologic characteristics of microsatellite instability-low esophagogasrtric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses. Int J Cancer 2021; 148(5): 1260-1275.
  2. Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, Shimizu H, Okada M, Toh Y, Doki Y, Endo S, Fukuda H, Hirata Y, Iwata H, Kobayashi J, Kumamaru H, Miyata H, Motomura N, Natsugoe S, Ozawa S, Saiki Y, Saito A, Saji H, Sato Y, Taketani T, Tanemoto K, Tangoku A, Tatsuishi W, Tsukihara H, Watanabe M, Yamamoto H, Minatoya K, Yokoi K, Okita Y, Tsuchida M, Sawa Y. Thoracic and Cardiovascular surgeries in Japan during 2018. Gen Thorac Cardiovasc Surg 2021; 69(1): 179-212.
  3. Watanabe M, Tachimori Y, Oyama T, Toh Y, Matsubara H, Ueno M, Kono K, Uno T, Ishihara R, Muro K, Numasaki H, Tanaka K, Ozawa S, Murakami K, Usune S, Takahashi A, Miyata H, The Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Comprehensive registry of esophageal cancer in Japan, 2013. Esophagus, 2021; 18(1): 1-24.
  4. Okamura A, Watanabe M, Kanamori J, Imamura Y, Takahashi K, Ushida Y, Kamiyama R, Seto A, Shimbashi W, Sasaki K, Fukushima H, Yonekawa H, Mitani H. Digestive reconstruction after pharyngolaryngectomy with total esophagectomy. Ann Surg Oncol 2021; 28(2): 695-701.
  5. Okamura A, Matsuda S, Mayanagi S, Kanamori J, Imamura Y, Irino T, Kawakubo H, Mine S, Takeuchi H, Kitagawa Y, Watanabe M. Clinical significance of pretherapeutic serum squamous cell antigen level in patients with neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28(2): 1209-1216.
  6. Otake R, Okamura A, Yamashita K, Imamura Y, Kanamori J, Kozuki R, Takahashi K, Toihata T, Yamamoto N, Asari T, Mine S, Watanabe M. Efficacy of postoperative radiotherapy in esophageal squamous cell carcinoma patients with positive circumferential resection margin. Esophagus 2021; 18: 288-295.
  7. Takahashi K, Watanabe M, Ushida Y, Kozuki R, Toihata T, Otake R, Kanamori J, Okamura A, Imamura Y, Mine S. Comparison of the outcomes between total eversion and conventional triangulating stapling technique in cervical esophagogastric anastomosis after esophagectomy: A propensity-score matched analysis. Esophagus 2021; 18: 475-481.
  8. Takahashi K, Watanabe M, Kanie Y, Otake R, Kozuki R, Toihata T, Okamura A, Kanamori J, Imamura Y. Significance of D-dimer-based screening for detecting preoperative venous thromboembolism in patients with esophageal cancer after neoadjuvant chemotherapy. Int J Clin Oncol, 2021; 26: 1083-1090.
  9. Hatamori H, Yoshio T, Tokai Y, Namikawa K, Yoshimizu S, Horiuchi Y, Tsuchida T, Ishiyama A, Hirasawa T, Kanamori J, Okamura A, Imamura Y, Watanabe M, Fujisaki J. Efficacy of endoscopic filling with polyglycolic acid sheets and fibrin glue for anastomotic leak after esophageal cancer surgery: identification of an optimal technique. Esophagus, 2021; 18: 529-536.
  10. Mori K, Sugawara K, Aikou S, Yamashita H, Yamashita K, Ogura M, Chin K, Watanabe M, Matsubara H, Yoh Y, Kakeji Y, Seto Y. Esophageal cancer patients survival after complete response to definitive chemoradiotherapy: a retrospective analysis. Esophagus 2021; 18: 629-637.
  11. Kanamori J, Watanabe M, Kozuki R, Toihata T, Otake R, Takahashi K, Okamura A, Imamura Y, Mine S. Successful transition from open to minimally invasive approach in Ivor Lewis esophagectomy: a single-center experience in Japan. Langenbecks Arch Surg 2021; 406: 1407-1414.
  12. Kanie Y, Okamura A, Maruyama S, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Watanabe M. Clinical significance of serum squamous cell antigen in patients with recurrent esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28: 7990-7996.
  13. Maruyama S, Okamura A, Ishizuka N, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Watanabe M. Airflow limitation predicts postoperative pneumonia after esophagectomy. World J Surg2021; 45: 2492-2500.
  14. Maruyama S, Okamura A, Watanabe M. Author's reply: Comparison of outcomes between additional esophagectomy after noncurative endoscopic resection and upfront esophagectomy for T1N0 esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28: 4859-4866.
  15. Maruyama S, Okamura A, Watanabe M. Authors' Reply: Comparison of outcomes between additional esophagectomy after noncurative endoscopic resection and upfront esophagectomy for T1N0 esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28: 839-840.
  16. Maruyama S, Okamura A, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Watanabe M. Influence of damaged stomach on anastomotic leakage following cervical esophagogastrostomy in patients with esophageal cancer. Ann Surg Oncol 2021; 28: 4859-4866.
  17. Kanie Y, Okamura A, Asari T, Maruyama S, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Ishiyama A, Yoshio T, Tsuchida T, Chin K, Watanabe M. Additional treatment following noncurative endoscopic resection for esophageal squamous cell carcinoma: A comparison of outcomes between esophagectomy and chemoradiotherapy. Ann Surg Oncol 2021; 28: 8428-8433.
  18. Kanie Y, Okamura A, Asari T, Maruyama S, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Ishiyama A, Yoshio T, Tsuchida T, Chin K, Watanabe M. ASO Visual abstract: Additional Treatment following noncurative endoscopic resection for esophageal squamous cell carcinoma - A comparison of outcomes between esophagectomy and chemoradiotherapy. Ann Surg Oncol 2021; 28: 477-478.
  19. Okamura A, Watanabe M, Mukoyama N, Ota Y, Shiraishi O, Shimbashi W, Baba Y, Matsui H, Shinomiya H, Sugiura K, Morita M, Sakai M, Sato H, Shibata T, Nasu M, Matsumoto S, Toh Y, Shiotani A, the Japane Broncho-esophagological Society, Pharyngolaryngectomy with Total Esophagectomy (JBES-PLTE) Study Group. Ann Gastroenterol Surg 2021; 22: 54-62.
  20. Matsuda S, Kawakubo H, Okamura A, Takahashi K, Toihata T, Takemura R, Mayanagi S, Takeuchi H, Watanabe M, Kitagawa Y. Prognostic significance of stratification using pathological stage and response to neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28: 8438-8449.
  21. Maruyama S, Okamura A, Watanabe M. ASO author reflections: Additional esophagectomy after noncurative endoscopic resection versus upfront esophagectomy in patients with T1N0 esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28: 4867-4868.
  22. Kanie Y, Okamura A, Watanabe M. ASO Author Reflections: Serum squamous cell antigen in recurrent esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28: 7997-7998.
  23. Kanie Y, Okamura A, Asari T, Ishiyama A, Yoshio T, Tsuchida T, Chin K, Watanabe M. ASO Author reflections: Esophagectomy or chemoradiotherapy, that is the question: Additional treatment following noncurative endoscopic resection for esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28: 8436-8437.
  24. Maruyama S, Okamura A, Watanabe M. ASO Author Reflections: Does damaged stomach increase the risk of anastomotic leakage after esophagectomy? Ann Surg Oncol 2021; 28: 7247-7248.
  25. Maruyama S, Okamura A, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Watanabe M. ASO Visual Abstract: Influence of damaged stomach on anastomotic leakage after cervical esophagogastrostomy for patients with esophageal cancer. Ann Surg Oncol 2021; 28: 464.
  26. Matsuda S, Kawakubo H, Okamura A, Takahashi K, Toihata T, Takemura R, Mayanagi S, Takeuchi H, Watanabe M, Kitagawa Y. ASO author reflection: Response to neoadjuvant chemotherapy strengthens the prognostic impact of pathological stage for esophageal squamous cell carcinoma. Ann Surg Oncol 2021; 28: 8448-8449.
  27. Watanabe M. Additional esophagectomy following noncurative endoscopic resection for esophageal squamous cell carcinoma: Is it a reasonable strategy? Ann Surg Oncol 2021; 28: 6923-6924.
  28. 小口正彦、渡邊雅之、鈴木一洋、月村駿、佐野武：AI時代のクリニカルパス．外科 2021; 83(1): 14-17.
  29. 岡村明彦、髙橋慶太、丸山傑、蟹江恭和、藤原大介、金森淳、今村裕、渡邊雅之：術後合併症をいかに防ぐかーコツとポイント　食道癌術後の吻合部狭窄　三辺外翻三角吻合の概要とピットフォール．臨床外科 2021; 76(1): 19-23.
  30. 岡村明彦、丸山傑、蟹江恭和、坂本啓、藤原大介、渡邊雅之：上部消化管手術におけるトラブルシューティングー困難症例・偶発症への対策　食道切除後胃管血流不良（術中）に対する対処．手術　増刊号　2021; 75 (7) 1113-1117.
  31. 坂本啓、岡村明彦、髙橋慶太、金森淳、今村裕、渡邊雅之：手術手技　食道亜全摘・頸部胃管吻合における三辺外翻三角吻合．手術増刊号　2021; 76(7): 1219-1224.
  32. 渡邊雅之、佐野武：コロナとの対峙　外科診療の変容とポストコロナへ向けて　６．外科治療への影響　2)手術：日本外科学会雑誌　2021; 122: 618-624.
  33. 蟹江恭和、岡村明彦、大木暁、陳勁松、渡邊雅之：食道扁平上皮癌手術後の再発に対する治療．日本気管食道科学会「専門医通信」　2021; 63: 24-28.
  34. 金森淳、渡邊雅之、丸山傑、藤原大介、蟹江恭和、坂本啓、岡村明彦、今村裕：若手外科医のための食道手術ハンドブック　胸部食道癌に対する手術手技　頸部郭清　臨床外科 2021; 76(7): 828-834.

【2020】

  1. Okamura A, Hayami M, Kozuki R, Takahashi K, Toihata T, Imamura Y, Mine S, Watanabe M. Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma. Esophagus, 2020; 17(1): 59-66.
  2. Watanabe M, Nakajima M, Nishikawa K, Kato H, Matsubara H. Thoracic endovascular aortic repair for esophageal cancer invading the thoracic aorta- A questionnaire survey study. Esophagus, 2020; 17(1): 74-80.
  3. Watanabe M, Sato M, Fukuchi M, Kato H, Matsubara H. Treatment of aortoesophageal fistula developed after thoracic endovascular aortic repair: a questionnaire survey study. Esophagus 2020; 17(1): 81-86.
  4. Hayami M, Watanabe M, Mine S, Imamura Y, Okamura A, Yuda M, Yamashita K, Shoji Y, Toihata T, Kozuki R, Ishizuka N. Steam induced by the activation of energy devices under a wet condition may cause thermal injury. Surg Endosc 2020; 34(5): 2295-2302.
  5. Suzuki T, Okamura A, Watanabe M, Mine S, Imamura Y, Asari T, Osumi H, Nakayama I, Ichimura T, Ogura M, Doki A, Takahari D, Yamaguchi K, Chin K. Neoadjuvant chemoradiotherapy with cisplatin plus fluorouracil for borderline resectable esophageal squamous cell carcinoma. Ann Surg Oncol, 2020; 27(5): 1510-1517.
  6. Takahashi K, Okamura A, Amada E, Otake R, Kozuki R, Toihata T, Imamura Y, Watanabe M. Esophagectomy for esophageal cancer in a patient with left pulmonary artery sling. Ann Surg Oncol, 2020; 27(5): 1530.
  7. Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, Shimizu H, Okada M, Tangoku A, Doki Y, Endo S, Fukuda H, Hirata Y, Iwata H, Kobayashi J, Kumamaru H, Miyata H, Motomura N, Natsugoe S, Ozawa S, Saiki Y, Saito A, Saji H, Sato Y, Taketani T, Tanemoto K, Tatsuishi W, Toh Y, Tsukihara H, Watanabe M, Yamamoto H, Yokoi K, Okita Y. Thoracic and Cardiovascular surgeries in Japan during 2017: Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2020; 68(4): 414-449.
  8. Okamura A, Watanabe M, Kitazono S, Manoshiro H, Kasama E, Takahash K, Toihata T, Otake R, Kozuki R, Imamura Y, Ishizuka N. The Design of and rationale for the effect of perioperative inhaled tiotropium for patients with chronic obstructive pulmonary disease in esophageal cancer Surgery (EPITOPE): an open-label, randomized parallel-group study. Eur Surg Res 2020; 61(4-5): 123-129.
  9. Suzuki T, Okamura A, Watanabe M, Chin K. ASO author reflections: How should we approach borderline resectable esophageal squamous cell carcinoma? Ann Surg Oncol 2020; 27(5): 1518-1519.
  10. Kurogochi T, Honda M, Yamashita K, Hayami M, Okamura A, Imamura Y, Mine S, Watanabe M. Correction to: Safety and efficacy of preoperative chemotherapy followed by esophagectomy versus upfront surgery for resectable esophageal squamous cell carcinoma. Surg Today 2020; 50(6): 632.
  11. Yuda M., Yamashita K., Okamura A., Hayami M., Fukudome I., Toihata T., Imamura Y., Mine S., Ishizuka N., Watanabe M. Influence of preoperative orophryngeal microflora on the occurrence of postoperative pneumonia and survival in patients undergoing esophagectomy for esophageal cancer. Ann Surg 2020; 272(6): 1035-1043.
  12. Otake R, Okamura A, Kanamori J, Takahashi K, Ushida Y, Imamura Y, Mine S, Watanabe M. The optimal feeding enterostomy creation during esophagectomy to reduce the long-term risk of small bowel obstruction. World J Surg 2020; 44(11): 3845-3851.
  13. Watanabe M, Otake R, Kozuki R, Toihata T, Takahashi K, Okamura A, Imamura Y. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surgery Today 2020; 50(1): 12-20.
  14. Watanabe M, Otake R, Kozuki R, Toihata T, Takahashi K, Okamura A, Imamura Y. Correction to: Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today 2020; 50(4): 425.
  15. Imamura Y, Watanabe M, Oki E, Morita M, Baba H. Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study. Ann Gastroenterol Surg 2020; 5(1):46-59.
  16. Watanabe M. Salvage esophagectomy for residual tumor after definitive chemoradiotherapy for esophageal squamous cell carcinoma invading the neighboring organs: Is it a feasible choice? Ann Surg Oncol 2020; 27: 317-3108.
  17. Takahashi K, Okamura A, Watanabe M. ASO author reflections: Cervicothoracoscopic esophagectomy for esophageal cancer. Ann Surg Oncol 2020; 27(5): 1531-1532.
  18. Okamura A, Matsuda S, Kawakubo H, Mine S, Takeuchi H, Kitagawa Y, Watanabe M. ASO author reflections: Prediction of the therapeutic efficacy in patients with neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2020; 27(Suppl 3): 795-796.
  19. Okamura A, Watanabe M, Mitani M. ASO author reflections: What is the optimal method of digestive reconstruction following pharyngolaryngectomy with total esophagectomy. Ann Surg Oncol. 2020; 27(Suppl 3): 824-825.
  20. 渡邊雅之、大竹玲子、上月遼太郎、髙橋慶太、問端輔、岡村明彦、今村裕：食道癌に対するサルベージ手術の適応と成績．日本気管食道科学会会報　2020; 71(4): 130-132.
  21. 鳥居淳一、新橋渉、三谷浩樹、渡邊雅之、今村裕、岡村明彦、瀬戸陽、神山亮介、渡嘉敷邦彦、川端一嘉：放射線治療後の遺残・再燃例に対する咽頭喉頭全摘・食道全摘症例の検討．日本気管食道科学会誌 2020; 71(4): 297-305.
  22. 岡村明彦、渡邊雅之、上月亮太郎、髙橋慶太、問端輔、今村裕、峯真司：食道癌診療の現況と展望：根治的化学放射線療法とサルベージ手術．日本外科学会雑誌 2020; 121(4): 448-452.
  23. 高橋慶太、大竹玲子、堀創史、問端輔、上月亮太郎、岡村明彦、今村裕、渡邊雅之．頸部食道移管吻合：器械吻合（三辺外翻参画吻合）．臨床外科　2020; 75: 157-160.
  24. 渡邊雅之、堀　創史、大竹玲子、上月亮太郎、問端　輔、髙橋慶太．消化器外科手術：論点2020：食道切除後の標準的再建ルート：胸骨後再建の立場から．手術　2020; 74: 439-446.
  25. 渡邊雅之、上月亮太郎：【特集】ハイリスク胸部外科手術：臓器予備力が低下した高齢者における食道癌手術と周術期管理．胸部外科2020; 73: 870-875.
  26. 渡邊雅之、髙橋慶太、岡村明彦、金森淳、今村裕：早わかり　縫合・吻合のすべて　術式別の縫合・吻合法：頸部食道―胃管吻合：リニアステープラー：三角吻合．臨床外科2020；75：112-114.
  27. 渡邊雅之：胸部食道癌に対する体腔鏡下手術のこれから．日本医事新報2020; 5023: 51-52.

【2019】

  1. Baba Y, Yagi T, Kosumi K, Okadome K, Nomoto D, Eto K, Hiyoshi Y, Nagai Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Komohara Y, Watanabe M, Baba H. Morphological lymphatic reaction, patient prognosis and PD-1 expression after surgical resection for oesophageal cancer. Br J Surg 2019; 106(10): 1352-1361.
  2. Yoshida N., Nagai Y., Baba Y., Miyamoto Y., Iwagami S., Iwatsuki M., Hiyoshi Y., Eto K., Ishimoto T., Kiyozumi Y., Nomoto D., Akiyama T., Imamura Y., Watanabe M., Baba H. Effect of resection of the thoracic duct and surrounding lymph nodes on short- and long- term and nutritional outcomes after esophagectomy for esophageal cancer. Ann Surg Oncol 2019; 26(9): 1893-1900.
  3. Hayami M., Watanabe M., Mine S., Imamura Y., Okamura A., Yuda M., Yamashita K., Toihata T., Shoji Y., Ishizuka N. Lateral thermal spread induced by energy devices: a porcine model to evaluate the influence on the recurrent laryngeal nerve. Surg Endosc 2019; 33(12): 4153-4163.
  4. Yamashita K., Mine S., Toihata T., Fukudome I., Okamura A., Yuda M., Hayami M., Imamura Y., Watanabe M. The usefulness of three-dimentional video-assisted thoracoscopic esophagectomy in esophageal cancer patients. Esophagus 2019; 16(3): 272-277.
  5. Takahashi K, Mine S, Kozuki R, Toihata T, Okamura A, Imamura Y, Watanabe M. Ivor-Lewis esophagectomy for patients with squamous cell carcinoma of the thoracic esophagus with a history of total pharyngolaryngectomy. Esophagus 2019; 16(4): 382-385.
  6. Kurogochi T, Honda M, Yamashita K, Hayami M, Okamura A, Imamura Y, Mine S, Watanabe M. Safety and efficacy of preoperative chemotherapy followed by esophagectomy versus upfront surgery for resectable esophageal squamous cell carcinoma. Surg Today. 2019; 49 (2): 150-157.
  7. Yagi T, Baba Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Baba H. PD-L1 expression, tumor-infiltrating lymphocytes, and clinical outcome in patients with surgically resected esophageal cancer Ann Surg 2019; 269(3): 471-478.
  8. Yagi T., Baba Y., Okadome K., Kiyozumi Y., Hiyoshi Y., Ishimoto T., Iwatsuki M., Miyamoto Y., Yoshida N., Watanabe M., Kamohara Y., Baba H. Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer. Eur J Cancer 2019; 111: 38-49.
  9. Hirayama, Y., Fujisaki, J., Yoshimizu, S., Horiuchi, Y., Yoshio, T., Ishiyama, A., Hirasawa, T., Imamura, Y., Mine, S., Watanabe, M.,  Tsuchida, T.　Efficacy and safety of endoscopic resection for gastric tube cancer after surgical resection of esophageal squamous cell carcinoma　Esophagus, 2019; 16(2): 194-200.
  10. Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ogata Y, Hitoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Idoleamine 2,3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer Cancer Sci 2019; 110(6): 1863-1871.
  11. Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Kamohara Y, Baba H. IDO1 expression is associated with immune tolerance and poor prognosis in patients with surgically resected esophageal cancer. Ann Surg 2019; 269(6): 1101-1108.
  12. Mine S, Watanabe M, Kumagai K, Okamura A, Yuda M, Hayami M, Yamashita K, Imamura Y, Ishizuka N. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction. Dis Esophagus 2019; 32(11): 1-8.
  13. Mine S, Watanabe M. Reply to: Is there really no difference of mediastinal lymph node metastasis pattern between esophageal adenocarcinoma and squamous cell carcinoma? Dis Esophagus 2019; 32(7)
  14. Yoshida N, Morito A, Nagai Y, Baba Y, Miyamoto Y, Iwagami S, Iwatsuki M, Hiyoshi Y, Eto K, Ishimoto T, Kiyozumi Y, Yagi T, Nomoto D, Akiyama T, Toihata T, Imamura Y, Watanabe M, Baba H. Clinical importance of sputum in the respiratory tract as a predictive marker of postoperative morbidity after esophagectomy for esophageal cancer. Ann Surg Oncol. 2019; 26(8)2580-2586.
  15. Okamura A, Watanabe M, Kozuki R, Toihata T, Takahashi K, Imamura Y, Mine S. Significance of intramural metastasis in patients with esophageal squamous cell carcinoma: An indicator of aggressive cancer behavior. World J Surg 2019; 43(8): 1997-2005.
  16. Takahashi K, Watanabe M, Kozuki R, Toihata T, Okamura A, Imamura Y, Mine S, Ishizuka N. Prognostic significance of skeletal muscle loss during early postoperative period in elderly patients with esophageal cancer. Ann Surg Oncol 2019; 26(11):3727-3735.
  17. Okamura A, Watanabe M. Author's reply: Significance of intramural metastasis in patients with esophageal squamous cell carcinoma: An indicator of aggressive cancer behavior. World J Surg 2019; 43(10): 2649-2650.
  18. Toh Y, Yamamoto H, Miyata H, Gotoh M, Watanabe M, Matsubara H, Kakeji Y, Seto Y. . Significance of the board-certified surgeon systems and clinical practice guideline adherence to surgical treatment of esophageal cancer in Japan: a questionnaire survey of departments registered in the National Clinical Database. Esophagus 2019; 16(4): 362-370.
  19. Kalikawe R, Baba Y, Nomoto D, Okadome K, Miyake K, Eto K, Hiyoshi Y, Nagai Y, Iwatski M, Ishimoto T, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Lysyl oxidase impacts disease outcomes and correlates with grobal DNA hypomethylation in esophageal cancer. Cancer Sci 2019; 110 (12): 3727-3737.
  20. Okamura A, Yamaashita K, Kozuki R, Takahashi K, Toihata T, Imamura Y, Mine S, Watanabe M. Inflammatory response and recurrence after minimally invasive esophagectomy. Langenbecks Arch Surg 2019, 404(6): 761-769.
  21. Imamura, Y., Watanabe, M., Toihata, T., Takamatsu, M., Kawachi, H., Haraguchi, I., Ogata, Y., Yoshida, N., Saeki, H., Oki, E., Taguchi, K., Yamamoto, M., Morita, M., Mine, S., Hiki, N., Baba, H., Sano, T.　Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients　Digestion, 99(1): 6-13, 2019    
  22. 渡邊雅之、峯真司、高橋慶太、問端輔、上月亮太郎、今村裕、岡村明彦．食道癌における頸部郭清術　胸部食道癌に対する鎖骨上リンパ節郭清の意義．日本気管食道科学会会報　2019; 70: 164-167.
  23. 岡村明彦、渡邊雅之、上月亮太郎、高橋慶太、問端輔、今村裕、峯真司．食道扁平上皮癌における壁内転移の意義．日本気管食道科学会会報 2019; 70: 225-230.
  24. 高橋慶太、上月亮太郎、問端輔、岡村明彦、今村裕、峯真司、渡邊雅之．人生100年時代における高齢者栄養療法　高齢者食道癌術後の骨格筋減少が再発・予後に与える影響について．外科と代謝・栄養．2019; 53: 92.
  25. 渡邊雅之．ナースがおさえる正常＆異常のポイントこれだけ！消化器癌治療後の過程　まるみえ！タイムライン：食道の治療とケア．消化器外科Nursing 2019; 24: 410-417.
  26. 岡村明彦、渡邊雅之、上月亮太郎、高橋慶太、問端輔、今村裕、峯真司．食道癌手術　術中・術後合併症を起こさないコツ：術中・術後合併症を軽減する手術主義の工夫と周術期管理．消化器外科2019; 42: 913-922.
  27. 渡邊雅之、大竹玲子、問端輔、高橋慶太、上月亮太郎、岡村明彦、今村裕．食道癌に対する気管分岐部および気管支周囲リンパ節郭清．消化器外科　2019; 42: 1309-1317.
  28. 渡邊雅之、岡村明彦、上月亮太郎、高橋慶太、問端輔、大竹玲子、陳勁松、鈴木健、羽田忍、高瀬鮎美、早坂紀子．【臓器別がん　Basic & New　症例FILE付き　食道がん】．YORI-SOU がんナーシング　2019; 9: 733-748.

【2018】

  1. Okamura A, Watanabe M, Imamura Y, Hayami M, Yuda M, Yamashita K, Shoji Y, Mine S: Cervicothoracoscopic approach in esophagectomy. Ann Surg Oncol. 2018; 25(1), 333.
  2. Pectasides E, Stachler MD, Derks S, Liu Y, Maron S, Islam M, Alpert L, Kwak H, Kindler H, Polite B, Sharma MR, Allen K, O'Day E, Lomnicki S, Maranto M, Kanteti R, Fitzpatrick C, Weber C, Setia N, Xiao SY, Hart J, Nagy R, Kim KM, Choi MG, Min BH, Nason KS, O'Keefe L, Watanabe M, Baba H, Lanman R, Agoston AT, Oh DJ, Dunford A, Thorner AR, Ducar MD, Wollison BM, Coleman HA, Ji Y, Posner MC, Roggin KK, Turaga K, Chang P, Hogarth K, Siddiqui U, Gelrud A, Ha G, Freeman SS, Rhoades J, Reed S, Gydush G, Rotem D, Davison J, Imamura Y, Adalsteinsson V, Lee J, Bass AJ, Catenacci DV: Genomic heterogeniety as a barrier to precision medicine in gastroesophageal adenocarcinoma. Cancer Discov 2018; 8(1): 37-48.
  3. Hayami M, Watanabe M, Ishizuka N, Nine S, Imamura Y, Okamura A, Kurogochi T, Yamashita K: Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy. J Surg Oncol, 2018; 117(6): 1251-1259.
  4. Okamura A, Watanabe M, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S: Implication of visceral obesity in patients with esophageal squamous cell carcinoma. Langenbeck Arch Surg. 2018; 403(2): 245-253.
  5. Okamura A, Watanabe M, Yuda M, Shoji Y, Yamashita K, Hayami M, Imamura Y, Mine S:　Cervicothoracoscopic Approach for Esophageal Cancer in a Patient with Right-Sided Aortic Arch　Ann Surg Oncol. 2018; 25(5): 1287.
  6. Yamashita K, Watanabe M, Mine S, Fukudome I, Okamura A, Yuda M, Hayami M, Imamura Y: The impact of the Charlson comorbidity index on the prognosis of esophageal cancer patients who underwent esophagectomy with curative intent.　Surg Today, 2018; 48(6): 632-639.
  7. Okamura A, Watanabe M, Fukudome I, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S: Surgical team proficiency in minimally invasive esophagectomy is related to case volume and improves patient outcome. Esophagus 2018; 15(2): 115-121.
  8. Wong GS, Zhou J, Liu JB, Wu Z, Xu X, Li T, Schumacher SE, Puschhof J, McFarland J, Zou C, Dulak A, Henderson L, Xu P, O'Day E, Rendak R, Liao WL, Cecchi F, Hembrough T, Schwartz S, Szeto C, Rustgi AK, Wong KK, Diehl JA, Jensen K, Graziano F, Ruzzo A, Fereshetian S, Merthins P, Carr SA, Beroukhim R, Nakamura K, Oki E, Watanabe M, Baba H, Imamura Y, Catenacci D, Bass AJ. Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 2018; 24(7): 968-977.
  9. Okamura A, Watanabe M, Kozuki R, Toihata T, Yuda M, Imamura Y, Mine S: Supraclavicular and celiac metastases in squamous cell carcinoma of the middle thoracic esophagus. Langenbecks Arch Surg, 2018; 403(8): 977-984.    
  10. Cañadas I, Thummalapalli R, Kim JW, Kitajima S, Jenkins RW, Christensen CL, Campisi M, Kuang Y, Zhang Y, Gjini E, Zhang G, Tian T, Sen DR, Miao D, Imamura Y, Thai T, Piel B, Terai H, Aref AR, Hagan T, Koyama S, Watanabe M, Baba H, Adeni AE, Lydon CA, Tamayo P, Wei Z, Herlyn M, Barbie TU, Uppaluri R, Sholl LM, Sicinska E, Sands J, Rodig S, Wong KK, Paweletz CP, Watanabe H, Barbie DA: Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med. 2018, 24(8): 1143-1150.
  11. Yamashita K, Watanabe M, Mine S, Toihata T, Fukudome I, Okamura A, Yuda M, Hayami M, Ishizuka N, Imamura Y: Minimally-invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis. Surg Endosc 2018; 32(11): 4443-4450.
  12. Okamura A, Watanabe M, Fukudome I, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S: Relationship between visceral obesity and postoperative inflammatory response following minimally invasive esophagectomy. World J Surg 2018; 42(11):3651-3657.
  13. Bahcall M, Awad MM, Sholl LM, Wilson FH, Xu M, Wang S, Palakurthi S, Choi J, Ivanova EV, Leonardi GC, Ulrich BC, Pawelets CP, Kirschmeier PT, Watanabe M, Baba H, Nishino M, Nagy RJ, Lanman RB, Capelletti M, Chambers ES, Redig AJ, VanderLaan PA, Costa DB, Imamura Y, Janne PA: Amplification of wild-type KRAS impacts resistance to crizotinib in MET exon 14 mutant non-small cell lung cancer. Clin Cancer Res 2018, 24(23):5963-5976.
  14. Mine S, Watanabe M, Kumagai K, Okamura A, Yamashita K, Hayami M, Yuda M, Imamura Y, Ishizuka N: Oesophagectomy with or without supraclavicular lymphadenectomy after neoadjuvant treatment for squamous cell carcinoma of the oesophagus. Br J Surg 2018, 105:1793-1798.
  15. Watanabe M, Okamura A, Toihata T, Yamashita K, Yuda M, Hayami M, Fukudome I, Imamura Y, Mine S: Recent progress in perioperative management of patients undergoing esophagectomy for esophageal cancer. Esophagus, 2018; 15: 160-164.
  16. Watanabe M:
     Recent topics and perspectives on esophageal cancer in Japan. JMA journal, 2018; 1(1)30-39.
  17. Watanabe M:
     Introduction to the special issue on reviews of gastric cancer metastasis and treatment. J Cancer Metastasis Treat 2018; 4:48.
  18. Nakamura K, Iwatsuki M, Kurashige J, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Watanabe M, Baba H: Circulating tumor cells in gastric cancer. J Cancer Metastasis Treat. 2018; 4: 32.
  19. Toihata T, Imamura Y, Watanabe M, Baba H: Management of metastatic esophagogastric junction adenocarcinoma. J Cancer Metastasis Treat 2108; 4: 24.
  20. Ida S, Watanabe M: Coversion surgery for stage IV gastric cancer. J Cancer Metastasis Treat. 2018; 4: 22.
  21. Eto K, Ida S, Watanabe M, Baba H: Treatment strategy for metastatic gastric cancer in Japan. J Cancer Metastasis Treat. 2018; 4: 23.
  22. Watanabe M, Baba H: Biological basis of esophageal squamous cell carcinoma: Modern Thoracic Oncology, 1st edition. Singapore, World Scientific, 2018, pp3-5.
  23. 渡邊雅之：NEW BED-SIDE MEMO surgery．食道癌　大道学館出版部, 2018, pp1-29.
  24. 渡邊雅之:
    ベッドサイドメモ．食道癌　大道学館出版部, 2018, pp1-29.
  25. 渡邊雅之，問端　輔，上月亮太郎：食道再建術（再建のみ）．5年でマスター消化器外科標準手術　消化器外科専門医への道．メジカルビュー社, 2018, pp74-83.
  26. 渡邊雅之：消化器悪性疾患におけるビッグデータの意義と役割．4．胃癌．消化器疾患の最新医療．先端医療技術研究所, 2018, pp44-47.

このページのTOPへ